Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte Conference View Full Press Release Travere Therapeutics Launches “Play It Forward” Campaign to Celebrate the FSGS Community on Inaugural Awareness Day Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)